Motivation

  Can data be obtained from cerebrovascular structures?  

   What if detailed three-dimensional vascular condition information  could be obtained from TOF MRA source images?  

Rapid, accurate, and non-invasive measurement of cerebrovascular conditions based on TOF MRA.


As a new cerebrovascular biomarker, it enables the measurement of cerebrovascular wall shear stress.




The Future of Cerebrovascular Analysis,
Made Possible by NeuFlow.

A Next-Generation Cerebrovascular Analysis Solution Integrating the Best of CFD and PC-MR Technologies. 

Quickly and Easily Diagnoses Various Cerebrovascular Risk Factors, Including Cerebral Infarction, Stroke, and Aneurysms.

WHY VINT?

VINT reflects internal vascular conditions through TOF MRA.

An innovative solution for measuring and simultaneously visualizing cerebrovascular wall shear volume.

We provide SIG, a new cerebrovascular biomarker, offering a simpler and faster solution compared to traditional methods.

We facilitate more convenient communication with patients through their examination records.

What is SIG?

SIG (Signal Intensity Gradient) is not merely a factor for identifying specific diseases but a biomarker platform that can be utilized to determine the causes and prognoses of various cerebrovascular conditions.


SIG, as a surrogate marker, demonstrates a strong correlation with wall shear stress and represents the tangential force exerted by blood flow on the endothelial surface of the vessel.

The Future of Cerebrovascular Analysis,

Made Possible by NeuFlow

A Next-Generation Cerebrovascular Analysis Solution Integrating the Best of CFD and PC-MR Technologies.
Quickly and Easily Diagnoses Various Cerebrovascular Risk Factors, Including Cerebral Infarction, Stroke, and Aneurysms.
mobile background
WHY VINT?

VINT reflects internal vascular conditions
through TOF MRA.

An innovative solution for measuring and simultaneously visualizing cerebrovascular wall shear volume.

We provide SIG, a new cerebrovascular biomarker, offering a simpler and faster solution compared to traditional methods.

We facilitate more convenient communication with patients through their examination records.

What is SIG

SIG (Signal Intensity Gradient) is not merely a factor for identifying specific diseases

but a biomarker platform that can be utilized to determine the causes

and prognoses of various cerebrovascular conditions. 


SIG, as a surrogate marker, demonstrates a strong correlation with wall shear stress

and represents the tangential force exerted by blood flow

on the endothelial surface of the vessel.

How does VINT work? 

VINT enables easy and rapid SIG measurement through a simple process without requiring additional configurations.

   01. Automatic segmentation and 3D vascular object generation after DICOM import   

  02. Selection of vascular ROI (Region of Interest) and vessel labeling  

 03. Effective communication with patients through report generation 

mobile background

VINT enables easy and rapid SIG measurement

through a simple process without requiring additional configurations.

   01. Automatic segmentation and 3D vascular object generation after DICOM import   

  02. Selection of vascular ROI (Region of Interest) and vessel labeling  

 03. Effective communication with patients through report generation 

MediImg Co., Ltd. | Est. 2018

Business License No. : 313-87-00931

Head Office: #508, SBA Hub, Mapo-gu, Seoul, Korea

R&D Center: #6, 2F, Seoul National University Hospital Healthcare Innovation Park, Bundang, Gyeonggi-do, Korea

TEL : (+82) 02-484-5773 | FAX : (+82) 02-6499-6448

E-mail : info@mediimg.com

FDA 510K Approval Date : October 15, 2024

Copyright © 2025 MEDIIMG Co., Ltd. All rights reserved.


Approved by the MFDS

MediImg Co., Ltd. | Est. 2018 

Business License No. : 313-87-00931 

Head Office: #508, SBA Hub, Mapo-gu, Seoul, Korea

R&D Center: #6, 2F, Seoul National University Hospital Healthcare Innovation Park,

Bundang, Gyeonggi-do, Korea

TEL : (+82) 02-484-5773 | FAX : (+82) 02-6499-6448 | E-mail|info@mediimg.com

FDA 510K Approval Date : October 15, 2024

Approved by the MFDS


Copyright © 2025 MEDIIMG Co., Ltd. All rights reserved.